Top performer TCG secures two commitments from Rhode Island
The Column Group is close to reaching its fundraising target of $600m apiece for its early-stage life science Fund V and later-stage Opportunity Fund III.
The Column Group is close to reaching its fundraising target of $600m apiece for its early-stage life science Fund V and later-stage Opportunity Fund III.
Copyright PEI Media
Not for publication, email or dissemination